Zealand CEO: A news-heavy year
Denmark’s Zealand Pharma looks ahead to the second half of 2015 when the group expects to be able to make a number of significant announcements - announcements that might eventually lead to an acquisition.
BY STEFAN SINGH KAILAY
Last week, Zealand Pharma presented an annual report showing strengthened revenue and a smaller deficit, and these are the two results that the company’s chief executive Britt Meelby Jensen takes note of as well – that and a number of upcoming announcements.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
This is the size of Zealand chief’s golden handshake
For abonnenter
“Cash is king”
For abonnenter
Business chief to leave Zealand Pharma
For abonnenter
